Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome
- PMID: 3945904
- DOI: 10.1016/0090-3019(86)90233-8
Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome
Abstract
Out of 936 primary intracranial meningiomas, 94.3% were histologically benign (grade I), 4.7% atypical (grade II), and 1.0% anaplastic (grade III); one recurrence was sarcomatous (grade IV). Meningiomas with histologic anaplasia (grades II-IV) occurred in 12% of the men, but only 4% of the women. Only 26% of atypical or anaplastic meningiomas appeared completely innocent on a computed tomography scan. Angiograms, usually showing a meningeal feeding artery, suggested meningioma when computed tomography scans did not. At 5 years after complete removal, the recurrence rate was only 3% (21% at 25 years) for benign meningiomas, but 38% for atypical ones, and 78% for anaplastic ones. The median times to recurrence were 7.5, 2.4, and 3.5 years, respectively. In spite of postoperative radiotherapy, four of five anaplastic meningiomas recurred.
Similar articles
-
Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.Strahlenther Onkol. 2006 Nov;182(11):641-6. doi: 10.1007/s00066-006-1555-3. Strahlenther Onkol. 2006. PMID: 17072521
-
Computed tomography and angiography do not reliably discriminate malignant meningiomas from benign ones.Neuroradiology. 1990;32(2):94-7. doi: 10.1007/BF00588556. Neuroradiology. 1990. PMID: 2398947
-
The Influence of Adjuvant Radiotherapy in Atypical and Anaplastic Meningiomas: A Series of 88 Patients in a Single Institution.World Neurosurg. 2015 Jun;83(6):987-95. doi: 10.1016/j.wneu.2015.02.021. Epub 2015 Mar 11. World Neurosurg. 2015. PMID: 25769488
-
A Systematic Review of Ion Radiotherapy in Maintaining Local Control Regarding Atypical and Anaplastic Meningiomas.World Neurosurg. 2019 Dec;132:282-291. doi: 10.1016/j.wneu.2019.08.149. Epub 2019 Aug 30. World Neurosurg. 2019. PMID: 31476452
-
Role of adjuvant radiotherapy in atypical (WHO grade II) and anaplastic (WHO grade III) meningiomas: a systematic review.Clin Transl Oncol. 2021 Feb;23(2):205-221. doi: 10.1007/s12094-020-02434-3. Epub 2020 Jul 10. Clin Transl Oncol. 2021. PMID: 32651886
Cited by
-
Meningioma Genomics: Diagnostic, Prognostic, and Therapeutic Applications.Front Surg. 2016 Jul 6;3:40. doi: 10.3389/fsurg.2016.00040. eCollection 2016. Front Surg. 2016. PMID: 27458586 Free PMC article. Review.
-
Definitive embolization of meningiomas. A review.Interv Neuroradiol. 2005 Jun 30;11(2):179-88. doi: 10.1177/159101990501100210. Epub 2005 Oct 25. Interv Neuroradiol. 2005. PMID: 20584499 Free PMC article.
-
Implicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-I analysis of grades I and II meningioma tissue.J Neurooncol. 2008 Mar;87(1):43-50. doi: 10.1007/s11060-007-9498-9. Epub 2007 Nov 30. J Neurooncol. 2008. PMID: 18060363
-
Usefulness of thallium-201 SPECT in the evaluation of tumor natures in intracranial meningiomas.Neuroradiology. 2011 Nov;53(11):867-73. doi: 10.1007/s00234-010-0822-2. Epub 2011 Jan 8. Neuroradiology. 2011. PMID: 21221558
-
WHO grade II and III meningiomas: a study of prognostic factors.J Neurooncol. 2009 Dec;95(3):367-375. doi: 10.1007/s11060-009-9934-0. Epub 2009 Jun 27. J Neurooncol. 2009. PMID: 19562258
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical